BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32417854)

  • 1. Prevalence of Dyslipidemia in Patients with Acute Coronary Syndrome Admitted at Tertiary Care Hospital in Nepal: A Descriptive Cross-sectional Study.
    Dhungana SP; Mahato AK; Ghimire R; Shreewastav RK
    JNMA J Nepal Med Assoc; 2020 Apr; 58(224):204-208. PubMed ID: 32417854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dyslipidemia in Acute Non-cardioembolic Ischemic Stroke Patients at a Tertiary Care Centre: A Descriptive Cross-sectional Study.
    Shah SP; Shrestha A; Pandey SR; Sigdel K; Sah N; Panthi S; Basnet LB
    JNMA J Nepal Med Assoc; 2022 Mar; 60(247):241-245. PubMed ID: 35633254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Vitamin D Deficiency among Patients of Acute Coronary Syndrome in a Tertiary Care Center of Eastern Nepal.
    Nepal R; Karki P; Uraw S; Lamsal M
    JNMA J Nepal Med Assoc; 2021 Mar; 59(235):225-230. PubMed ID: 34506449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dyslipidemia among Patients with Ischemic Stroke in the Department of Medicine of a Tertiary Care Centre: A Descriptive Cross-sectional Study.
    Baral S; Pokhrel A; B K SK; Kshetri R; Regmi P; Gyawali P
    JNMA J Nepal Med Assoc; 2022 Jun; 60(250):511-516. PubMed ID: 35690976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyslipidemia among Patients with Ischemic Stroke Admitted to the Department of Medicine of a Tertiary Care Centre.
    Khadka T; Giri GK; Sherpa P; Ghimire U; Parajuli S; Pudasaini A; Shrestha S
    JNMA J Nepal Med Assoc; 2023 Sep; 61(265):718-722. PubMed ID: 38289800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyslipidemia among Pilots visiting a Tertiary Care Centre: A Descriptive Cross-sectional Study.
    Dawadi BR; Pokharel K
    JNMA J Nepal Med Assoc; 2023 Jan; 61(257):47-49. PubMed ID: 37203911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid profiles and prevalence of dyslipidemia in schoolchildren in south Khorasan Province, eastern Iran.
    Fesharakinia A; Zarban A; Sharifzadeh GR
    Arch Iran Med; 2008 Nov; 11(6):598-601. PubMed ID: 18976028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-density lipoprotein cholesterol target attainment in patients with stable or acute coronary heart disease in the Asia-Pacific region: results from the Dyslipidemia International Study II.
    Poh KK; Ambegaonkar B; Baxter CA; Brudi P; Buddhari W; Chiang FT; Horack M; Jang Y; Johnson B; Lautsch D; Sawhney J; Vyas A; Yan BP; Gitt AK
    Eur J Prev Cardiol; 2018 Dec; 25(18):1950-1963. PubMed ID: 30198749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyslipidemia and its predictors among adult workers in eastern Ethiopia: An institution-based cross-sectional study.
    Motuma A; Shiferaw K; Gobena T; Teji Roba K; Berhane Y; Worku A
    PLoS One; 2023; 18(10):e0291665. PubMed ID: 37812638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dyslipidemia in Patients with Type 2 Diabetes Mellitus in a Tertiary Care Centre: A Descriptive Cross-sectional Study.
    Mehta RK; Koirala P; Mallick RL; Parajuli S; Jha R
    JNMA J Nepal Med Assoc; 2021 Apr; 59(236):305-309. PubMed ID: 34508529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dyslipidemia in Patients with Xanthelasma Palpebrarum Visiting the Department of Dermatology of a Tertiary Care Centre: A Descriptive Cross-sectional Study.
    Rai A; Karki S; Prasad Sah S; Narayan Kamat L; Pradhan M
    JNMA J Nepal Med Assoc; 2022 Jun; 60(250):529-532. PubMed ID: 35690977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The utility of non-HDL in managing dyslipidemia of stage 5 chronic kidney disease.
    Pennell P; Leclercq B; Delahunty MI; Walters BA
    Clin Nephrol; 2006 Nov; 66(5):336-47. PubMed ID: 17140163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, patterns, and associations of dyslipidemia among Sri Lankan adults-Sri Lanka Diabetes and Cardiovascular Study in 2005-2006.
    Katulanda P; Dissanayake HA; De Silva SDN; Katulanda GW; Liyanage IK; Constantine GR; Sheriff R; Matthews DR
    J Clin Lipidol; 2018; 12(2):447-454. PubMed ID: 29429894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of dyslipidemia and associated risk factors in Turkish adults.
    Bayram F; Kocer D; Gundogan K; Kaya A; Demir O; Coskun R; Sabuncu T; Karaman A; Cesur M; Rizzo M; Toth PP; Gedik V
    J Clin Lipidol; 2014; 8(2):206-16. PubMed ID: 24636181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-lowering treatment and low-density lipoprotein cholesterol target achievement in patients with type 2 diabetes and acute coronary syndrome.
    Ferrières J; Lautsch D; Bramlage P; Horack M; Baxter CA; Ambegaonkar B; Toth PP; Poh KK; De Ferrari GM; Gitt AK
    Arch Cardiovasc Dis; 2020 Oct; 113(10):617-629. PubMed ID: 32873522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol goal achievement and lipid-lowering therapy in patients with stable or acute coronary heart disease in Singapore: results from the Dyslipidemia International Study II.
    Poh KK; Chin CT; Tong KL; Tan JKB; Lim JS; Yu W; Horack M; Vyas A; Lautsch D; Ambegaonkar B; Brudi P; Gitt AK
    Singapore Med J; 2019 Sep; 60(9):454-462. PubMed ID: 30773600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes.
    Roe MT; Li QH; Bhatt DL; Bittner VA; Diaz R; Goodman SG; Harrington RA; Jukema JW; Lopez-Jaramillo P; Lopes RD; Louie MJ; Moriarty PM; Szarek M; Vogel R; White HD; Zeiher AM; Baccara-Dinet MT; Steg PG; Schwartz GG
    Circulation; 2019 Nov; 140(19):1578-1589. PubMed ID: 31475572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein(a) and lipid profiles of patients awaiting coronary artery bypass graft; a cross sectional study.
    Bandara EM; Ekanayake S; Wanigatunge CA; Kapuruge A
    BMC Cardiovasc Disord; 2016 Nov; 16(1):213. PubMed ID: 27825299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II.
    Gitt AK; Lautsch D; Ferrières J; De Ferrari GM; Vyas A; Baxter CA; Bash LD; Ashton V; Horack M; Almahmeed W; Chiang FT; Poh KK; Brudi P; Ambegaonkar B
    Atherosclerosis; 2017 Nov; 266():158-166. PubMed ID: 29028484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dyslipidemias and cardiovascular risk scores in urban and rural populations in north-western Tanzania and southern Uganda.
    Kavishe B; Vanobberghen F; Katende D; Kapiga S; Munderi P; Baisley K; Biraro S; Mosha N; Mutungi G; Mghamba J; Hughes P; Smeeth L; Grosskurth H; Peck R
    PLoS One; 2019; 14(12):e0223189. PubMed ID: 31809516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.